Vikram Thermo India Ltd
- Market cap
- ₹ 968 Cr.
- P/E
- 27.5x
- P/B
- 6.72x
- 52-week range
- 132 – 464.7
- ROE
- 28%
- ROCE
- 36%
- Dividend yield
- 0.4%
- Debt / equity
- 0.03
- Sector
- Chemicals & Petrochemicals
- Industry
- Commodity Chemicals
- Listed on
- BSE
About
Vikram Thermo (India) Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of manufacturing of chemicals. It is engaged in manufacturing and selling of basic pharma co-polymer drug coat, diphenyl oxide, and others. The Company have both range of products basic pharma polymers as well as ready-mix coating products. Its brands include DRUGCOAT, DRCOAT, APION, AQUAPOL, and DPO-Diphenyl oxide. DRUGCOAT offers range of methacrylate co-polymer for enteric coating. DRCOAT offers ready to use tablet coating systems for enteric coating/ film coating/moisture barrier & specialty coating to pharmaceutical industries. The AQUAPOL is a line of acrylates polymers, which is a synthetic high molecular weight cross-linked water-soluble polymer of acrylic acid. AQUAPOL is used in cosmetic, pharmaceutical, and home industries. APION is an ion exchange polymer offers a solution to formulation problems, such as API disintegration and taste masking.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Commodity Chemicals: 75 companies →Vikram Thermo India Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)27.5 against a typical 22.7: pricier than most peers (1st = cheapest).39th of 72
- Sales growth+31% against a typical +12.7% from a year earlier.21st of 65
- Profit growth+62.5% against a typical +13.6% from a year earlier.14th of 49
- Share price, 3 months+57.1% against a typical −2.2%.4th of 65
- Size₹ 967.8 Cr. market value against a typical ₹ 131.2 Cr. (1st = largest).13th of 69
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 34 | 24 | 27 | 31 | 34 | 34 | 27 | 29 | 35 | 34 | 38 | 38 |
| Expenses | 22 | 15 | 20 | 20 | 21 | 21 | 20 | 17 | 19 | 19 | 26 | 20 |
| Operating Profit | 12 | 9 | 7 | 12 | 12 | 13 | 7 | 11 | 15 | 15 | 12 | 18 |
| OPM % | 36% | 39% | 27% | 37% | 37% | 39% | 25% | 40% | 45% | 44% | 32% | 48% |
| Other Income | 0 | 0 | 0 | −24 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 11 | 9 | 6 | −13 | 12 | 12 | 7 | 11 | 15 | 15 | 12 | 18 |
| Tax % | 26% | 27% | 23% | 23% | 16% | 23% | 41% | 25% | 25% | 25% | 29% | 26% |
| Net Profit | 8 | 6 | 5 | −16 | 10 | 9 | 4 | 8 | 11 | 11 | 9 | 13 |
| EPS in Rs | 2.63 | 2.05 | 1.57 | −5.04 | 3.12 | 2.87 | 1.3 | 2.53 | 3.53 | 3.49 | 2.71 | 4.23 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 13%
- 5 Years
- 13%
- 3 Years
- 6%
- TTM
- 17%
- 10 Years
- 25%
- 5 Years
- 26%
- 3 Years
- 32%
- TTM
- 34%
- 10 Years
- 34%
- 5 Years
- 49%
- 3 Years
- 38%
- TTM
- —
- 10 Years
- 17%
- 5 Years
- 19%
- 3 Years
- 20%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Vikram Thermo India Ltd | ₹ 384.90 | ₹ 968 Cr. | 27.5x | 6.7x | 28% | — |
| Sun Pharmaceutical Industries | ₹ 1,743.00 | ₹ 4,18,194 Cr. | 38.4x | 5.6x | 14.2% | 19.1% |
| Divi's Laboratories | ₹ 8,984.00 | ₹ 2,38,497 Cr. | 73.3x | 11.5x | 16.2% | 24.3% |
| Torrent Pharmaceuticals | ₹ 4,482.00 | ₹ 1,70,475 Cr. | 72.7x | 19.2x | 27.1% | 15.3% |
| Cipla | ₹ 1,337.00 | ₹ 1,08,011 Cr. | 27.6x | 3.3x | 11.8% | 13.7% |
| Zydus Lifesciences | ₹ 1,127.85 | ₹ 1,12,503 Cr. | 21.2x | 4.2x | 19.7% | 18.5% |
Management
- Dhirajlal Karsandas Patel
- Chairman of the Board, Managing Director
- Switi Patel
- Chief Financial Officer
- Ambalatbhai K. Patel
- Executive Director
- Ankur Patel
- Whole Time Director
- Dinesh H. Patel
- Whole Time Director
- S. R. Sanghavi
- Company Secretary
Prices are delayed and for information only. Nothing on this page is investment advice.